Skip to main content
Top
Published in: BMC Public Health 1/2010

Open Access 01-12-2010 | Review

Validation of population-based disease simulation models: a review of concepts and methods

Authors: Jacek A Kopec, Philippe Finès, Douglas G Manuel, David L Buckeridge, William M Flanagan, Jillian Oderkirk, Michal Abrahamowicz, Samuel Harper, Behnam Sharif, Anya Okhmatovskaia, Eric C Sayre, M Mushfiqur Rahman, Michael C Wolfson

Published in: BMC Public Health | Issue 1/2010

Login to get access

Abstract

Background

Computer simulation models are used increasingly to support public health research and policy, but questions about their quality persist. The purpose of this article is to review the principles and methods for validation of population-based disease simulation models.

Methods

We developed a comprehensive framework for validating population-based chronic disease simulation models and used this framework in a review of published model validation guidelines. Based on the review, we formulated a set of recommendations for gathering evidence of model credibility.

Results

Evidence of model credibility derives from examining: 1) the process of model development, 2) the performance of a model, and 3) the quality of decisions based on the model. Many important issues in model validation are insufficiently addressed by current guidelines. These issues include a detailed evaluation of different data sources, graphical representation of models, computer programming, model calibration, between-model comparisons, sensitivity analysis, and predictive validity. The role of external data in model validation depends on the purpose of the model (e.g., decision analysis versus prediction). More research is needed on the methods of comparing the quality of decisions based on different models.

Conclusion

As the role of simulation modeling in population health is increasing and models are becoming more complex, there is a need for further improvements in model validation methodology and common standards for evaluating model credibility.
Appendix
Available only for authorised users
Literature
3.
go back to reference Fone D, Hollinghurst S, Temple M, Round A, Lester N, Weightman A, Roberts K, Coyle E, Bevan G, Palmer S: Systematic review of the use and value of computer simulation modelling in population health and health care delivery. J Public Health Med. 2003, 25: 325-35. 10.1093/pubmed/fdg075.CrossRefPubMed Fone D, Hollinghurst S, Temple M, Round A, Lester N, Weightman A, Roberts K, Coyle E, Bevan G, Palmer S: Systematic review of the use and value of computer simulation modelling in population health and health care delivery. J Public Health Med. 2003, 25: 325-35. 10.1093/pubmed/fdg075.CrossRefPubMed
4.
go back to reference Weinstein MC, Toy EL, Sandberg EA, Neumann PJ, Evans JS, Kuntz KM, Graham JD, Hammitt JK: Modeling for health care and other policy decisions: uses, roles, and validity. Value Health. 2001, 4: 348-61. 10.1046/j.1524-4733.2001.45061.x.CrossRefPubMed Weinstein MC, Toy EL, Sandberg EA, Neumann PJ, Evans JS, Kuntz KM, Graham JD, Hammitt JK: Modeling for health care and other policy decisions: uses, roles, and validity. Value Health. 2001, 4: 348-61. 10.1046/j.1524-4733.2001.45061.x.CrossRefPubMed
5.
go back to reference Karnon JE, Goyder E, Tappenden P, McPhie S, Towers I, Brazier J, Madan J: A review and critique of modelling in prioritising and designing screening programmes. Health Technol Assess. 2007, 11 (52): 1-145.CrossRef Karnon JE, Goyder E, Tappenden P, McPhie S, Towers I, Brazier J, Madan J: A review and critique of modelling in prioritising and designing screening programmes. Health Technol Assess. 2007, 11 (52): 1-145.CrossRef
6.
go back to reference Gupta A, Harding A: Introduction and overview. Modelling our future. Edited by: Gupta A, Harding A. 2007, Amsterdam Elsevier, Inc, 15: 1-40. Gupta A, Harding A: Introduction and overview. Modelling our future. Edited by: Gupta A, Harding A. 2007, Amsterdam Elsevier, Inc, 15: 1-40.
8.
go back to reference Sargent RG: Verification and validation of simulation models. Proceedings of the 2005 Winter Simulation Conference. Edited by: Kuhl ME, Steiger NM, Armstrong FB, Joines JA. 2005, 130-143. full_text.CrossRef Sargent RG: Verification and validation of simulation models. Proceedings of the 2005 Winter Simulation Conference. Edited by: Kuhl ME, Steiger NM, Armstrong FB, Joines JA. 2005, 130-143. full_text.CrossRef
9.
go back to reference Citro CF, Hanushek EA: Validation. Improving information for social policy decisions The use of microsimulation modeling. Volume I: Review and recommendations. Edited by: Citro CF, Hanushek EA. 1994, Washington, DC: National Academy Press, 231-264. Citro CF, Hanushek EA: Validation. Improving information for social policy decisions The use of microsimulation modeling. Volume I: Review and recommendations. Edited by: Citro CF, Hanushek EA. 1994, Washington, DC: National Academy Press, 231-264.
10.
go back to reference Morrison R: DYNACAN Validation. 2007, DYNACAN Team, Statistics Canada, Ottawa, ON, Canada Morrison R: DYNACAN Validation. 2007, DYNACAN Team, Statistics Canada, Ottawa, ON, Canada
11.
go back to reference Weinstein MC, O'Brien B, Hornberger J, Jackson J, Johannesson M, McCabe C, Luce BR, ISPOR, Task Force on Good Research Practices--Modeling Studies: Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices -- Modeling Studies. Value Health. 2003, 6: 9-17. 10.1046/j.1524-4733.2003.00234.x.CrossRefPubMed Weinstein MC, O'Brien B, Hornberger J, Jackson J, Johannesson M, McCabe C, Luce BR, ISPOR, Task Force on Good Research Practices--Modeling Studies: Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices -- Modeling Studies. Value Health. 2003, 6: 9-17. 10.1046/j.1524-4733.2003.00234.x.CrossRefPubMed
12.
go back to reference Philips Z, Ginnelly L, Sculpher M, Claxton K, Golder S, Riemsma R, Woolacoot N, Glanville J: Review of guidelines for good practice in decision-analytic modelling in health technology assessment. Health Technol Assess. 2004, 8: iiiiv-ix xi, 1-158CrossRef Philips Z, Ginnelly L, Sculpher M, Claxton K, Golder S, Riemsma R, Woolacoot N, Glanville J: Review of guidelines for good practice in decision-analytic modelling in health technology assessment. Health Technol Assess. 2004, 8: iiiiv-ix xi, 1-158CrossRef
13.
go back to reference Sculpher M, Fenwick E, Claxton K: Assessing quality in decision analytic cost-effectiveness models. A suggested framework and example of application. Pharmacoeconomics. 2000, 17: 461-77. 10.2165/00019053-200017050-00005.CrossRefPubMed Sculpher M, Fenwick E, Claxton K: Assessing quality in decision analytic cost-effectiveness models. A suggested framework and example of application. Pharmacoeconomics. 2000, 17: 461-77. 10.2165/00019053-200017050-00005.CrossRefPubMed
14.
go back to reference Goeree R, O'Brien BJ, Blackhouse G: Principles of good modeling practice in healthcare cost-effectiveness studies. Expert Rev Pharmacoecon Outcomes Res. 2004, 4: 189-98. 10.1586/14737167.4.2.189.CrossRefPubMed Goeree R, O'Brien BJ, Blackhouse G: Principles of good modeling practice in healthcare cost-effectiveness studies. Expert Rev Pharmacoecon Outcomes Res. 2004, 4: 189-98. 10.1586/14737167.4.2.189.CrossRefPubMed
15.
16.
go back to reference Feuer EJ, Etzioni R, Cronin KA, Mariotto A: The use of modeling to understand the impact of screening on U.S. mortality: examples from mammography and PSA testing. Stat Methods Med Res. 2004, 13: 421-42. 10.1191/0962280204sm376ra.CrossRefPubMed Feuer EJ, Etzioni R, Cronin KA, Mariotto A: The use of modeling to understand the impact of screening on U.S. mortality: examples from mammography and PSA testing. Stat Methods Med Res. 2004, 13: 421-42. 10.1191/0962280204sm376ra.CrossRefPubMed
17.
go back to reference Wolfson MC: POHEM--a framework for understanding and modelling the health of human populations. World Health Stat Q. 1994, 47: 157-76.PubMed Wolfson MC: POHEM--a framework for understanding and modelling the health of human populations. World Health Stat Q. 1994, 47: 157-76.PubMed
18.
go back to reference Will BP, Berthelot J-M, Nobrega KM, Flanagan W, Evans WK: Canada's Population Health Model (POHEM): A tool for performing economic evaluations of cancer control interventions. Eur J Cancer. 2001, 37: 1797-1804. 10.1016/S0959-8049(01)00204-0.CrossRefPubMed Will BP, Berthelot J-M, Nobrega KM, Flanagan W, Evans WK: Canada's Population Health Model (POHEM): A tool for performing economic evaluations of cancer control interventions. Eur J Cancer. 2001, 37: 1797-1804. 10.1016/S0959-8049(01)00204-0.CrossRefPubMed
19.
go back to reference Will BP, Nobrega KM, Berthelot J-M, Flanagan W, Wolfson MC, Logan DM, Evans WK: First do no harm: Extending the debate on the provision of preventive tamoxifen. Br J Cancer. 2001, 85: 1280-8. 10.1054/bjoc.2001.2125.CrossRefPubMedPubMedCentral Will BP, Nobrega KM, Berthelot J-M, Flanagan W, Wolfson MC, Logan DM, Evans WK: First do no harm: Extending the debate on the provision of preventive tamoxifen. Br J Cancer. 2001, 85: 1280-8. 10.1054/bjoc.2001.2125.CrossRefPubMedPubMedCentral
20.
go back to reference Berthelot J-M, Will BP, Evans WK, Coyle D, Earle CC, Bordeleau L: Decision framework for chemotherapeutic interventions for metastatic non-small cell lung cancer. J Natl Cancer Inst. 2000, 92: 1321-29. 10.1093/jnci/92.16.1321.CrossRefPubMed Berthelot J-M, Will BP, Evans WK, Coyle D, Earle CC, Bordeleau L: Decision framework for chemotherapeutic interventions for metastatic non-small cell lung cancer. J Natl Cancer Inst. 2000, 92: 1321-29. 10.1093/jnci/92.16.1321.CrossRefPubMed
21.
go back to reference Flanagan W, Le Petit C, Berthelot J-M, White KJ, Coombs BA, Jones-McLean E: Potential impact of population-based colorectal cancer screening in Canada. Chronic Dis Can. 2003, 24: 81-88.PubMed Flanagan W, Le Petit C, Berthelot J-M, White KJ, Coombs BA, Jones-McLean E: Potential impact of population-based colorectal cancer screening in Canada. Chronic Dis Can. 2003, 24: 81-88.PubMed
22.
go back to reference Kopec JA, Sayre EC, Berthelot JM, Flanagan W, Fines P, Le Petit C, Cibere J, Rahman M, Lima VD, Aghajanian J, Bansback NJ, Anis AH, Jordan JM, Sobolev B, Greidanus NV, Garbuz DS, Hawker GA, Badley EM: Development of a computer simulation model of osteoarthritis in Canada. Osteoarthritis Cartilage. 2010, 18: 303-11. 10.1016/j.joca.2009.10.010.CrossRefPubMed Kopec JA, Sayre EC, Berthelot JM, Flanagan W, Fines P, Le Petit C, Cibere J, Rahman M, Lima VD, Aghajanian J, Bansback NJ, Anis AH, Jordan JM, Sobolev B, Greidanus NV, Garbuz DS, Hawker GA, Badley EM: Development of a computer simulation model of osteoarthritis in Canada. Osteoarthritis Cartilage. 2010, 18: 303-11. 10.1016/j.joca.2009.10.010.CrossRefPubMed
24.
go back to reference Habbema JD, Schechter CB, Cronin KA, Clarke LD, Feuer EJ: Modeling cancer natural history, epidemiology, and control: reflections on the CISNET breast group experience. J Natl Cancer Inst Monogr. 2006, 36: 122-6.CrossRefPubMed Habbema JD, Schechter CB, Cronin KA, Clarke LD, Feuer EJ: Modeling cancer natural history, epidemiology, and control: reflections on the CISNET breast group experience. J Natl Cancer Inst Monogr. 2006, 36: 122-6.CrossRefPubMed
25.
go back to reference Eddy DM, Schlessinger L: Archimedes: a trial-validated model of diabetes. Diabetes Care. 2003, 26: 3093-101. 10.2337/diacare.26.11.3093.CrossRefPubMed Eddy DM, Schlessinger L: Archimedes: a trial-validated model of diabetes. Diabetes Care. 2003, 26: 3093-101. 10.2337/diacare.26.11.3093.CrossRefPubMed
26.
go back to reference Eddy DM, Schlessinger L: Validation of the Archimedes diabetes model. Diabetes Care. 2003, 26: 3102-10. 10.2337/diacare.26.11.3102.CrossRefPubMed Eddy DM, Schlessinger L: Validation of the Archimedes diabetes model. Diabetes Care. 2003, 26: 3102-10. 10.2337/diacare.26.11.3102.CrossRefPubMed
28.
29.
go back to reference Greenland S, Pearl J, Robins JM: Causal diagrams for epidemiologic research. Epidemiology. 1999, 10: 37-48. 10.1097/00001648-199901000-00008.CrossRefPubMed Greenland S, Pearl J, Robins JM: Causal diagrams for epidemiologic research. Epidemiology. 1999, 10: 37-48. 10.1097/00001648-199901000-00008.CrossRefPubMed
30.
go back to reference Li W, Agrawala M, Aalesin D: Interactive image-based exploded view diagrams. ACM International Conference Proceeding Series. 2004, 62: 203-12. Li W, Agrawala M, Aalesin D: Interactive image-based exploded view diagrams. ACM International Conference Proceeding Series. 2004, 62: 203-12.
31.
go back to reference Hunink MG, Goldman L, Tosteson AN, Mittleman MA, Goldman PA, Williams LW, Tsevat J, Weinstein MC: The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment. JAMA. 1997, 277: 535-42. 10.1001/jama.277.7.535.CrossRefPubMed Hunink MG, Goldman L, Tosteson AN, Mittleman MA, Goldman PA, Williams LW, Tsevat J, Weinstein MC: The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment. JAMA. 1997, 277: 535-42. 10.1001/jama.277.7.535.CrossRefPubMed
33.
go back to reference Quantin C, Abrahamowicz M, Moreau T, Bartlett G, MacKenzie T, Tazi MA, Lalonde L, Faivre J: Variation over time of the effects of prognostic factors in a population-based study of colon cancer: comparison of statistical models. Am J Epidemiol. 1999, 150: 1188-200.CrossRefPubMed Quantin C, Abrahamowicz M, Moreau T, Bartlett G, MacKenzie T, Tazi MA, Lalonde L, Faivre J: Variation over time of the effects of prognostic factors in a population-based study of colon cancer: comparison of statistical models. Am J Epidemiol. 1999, 150: 1188-200.CrossRefPubMed
34.
go back to reference Kopec JA, Rahman MM, Berthelot J-M, Le Petit C, Aghajanian J, Sayre EC, Cibere J, Anis AH, Badley EM: Descriptive epidemiology of osteoarthritis in British Columbia, Canada. J Rheumatol. 2007, 34: 386-93.PubMed Kopec JA, Rahman MM, Berthelot J-M, Le Petit C, Aghajanian J, Sayre EC, Cibere J, Anis AH, Badley EM: Descriptive epidemiology of osteoarthritis in British Columbia, Canada. J Rheumatol. 2007, 34: 386-93.PubMed
35.
go back to reference Kane RL, Saleh KJ, Wilt TJ, Bershadsky B, Cross WW, MacDonald RM, Rutks I: Total knee replacement. Evidence report/technology assessment. Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services, Number 86, AHRQ Publication No. 04-E006-2. 2003 Kane RL, Saleh KJ, Wilt TJ, Bershadsky B, Cross WW, MacDonald RM, Rutks I: Total knee replacement. Evidence report/technology assessment. Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services, Number 86, AHRQ Publication No. 04-E006-2. 2003
36.
go back to reference Stout NK, Knudsen AB, Kong CY, McMahon PM, Gazelle GS: Calibration methods used in cancer simulation models and suggested reporting guidelines. Pharmacoeconomics. 2009, 27: 533-545. 10.2165/11314830-000000000-00000.CrossRefPubMedPubMedCentral Stout NK, Knudsen AB, Kong CY, McMahon PM, Gazelle GS: Calibration methods used in cancer simulation models and suggested reporting guidelines. Pharmacoeconomics. 2009, 27: 533-545. 10.2165/11314830-000000000-00000.CrossRefPubMedPubMedCentral
37.
go back to reference Weinstein MC: Recent developments in decision-analytic modelling for economic evaluation. Pharmacoeconomics. 2006, 24: 1043-53. 10.2165/00019053-200624110-00002.CrossRefPubMed Weinstein MC: Recent developments in decision-analytic modelling for economic evaluation. Pharmacoeconomics. 2006, 24: 1043-53. 10.2165/00019053-200624110-00002.CrossRefPubMed
38.
go back to reference Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JD, Feuer EJ, Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators: Effect of screening and adjuvant therapy on mortality from breast cancer. New Engl J Med. 2005, 353: 1784-92. 10.1056/NEJMoa050518.CrossRefPubMed Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JD, Feuer EJ, Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators: Effect of screening and adjuvant therapy on mortality from breast cancer. New Engl J Med. 2005, 353: 1784-92. 10.1056/NEJMoa050518.CrossRefPubMed
39.
go back to reference Groot Koerkamp B, Weinstein MC, Stijnen T, Heijenbrok-Kal MH, Hunink MG: Uncertainty and patient heterogeneity in medical decision models. Med Decis Making. 2010, 30: 194-205. 10.1177/0272989X09342277.CrossRef Groot Koerkamp B, Weinstein MC, Stijnen T, Heijenbrok-Kal MH, Hunink MG: Uncertainty and patient heterogeneity in medical decision models. Med Decis Making. 2010, 30: 194-205. 10.1177/0272989X09342277.CrossRef
40.
go back to reference Attaway S: MATLAB: A practical approach. 2009, Oxford: Elsevier, Inc Attaway S: MATLAB: A practical approach. 2009, Oxford: Elsevier, Inc
41.
go back to reference Chambers J: Software for Data Analysis: Programming with R. 2008, New York: Springer Science+Business MediaCrossRef Chambers J: Software for Data Analysis: Programming with R. 2008, New York: Springer Science+Business MediaCrossRef
45.
go back to reference Railsback SF: Agent-based simulation platforms: review and development recommendations. Simulation. 2006, 82: 609-23. 10.1177/0037549706073695.CrossRef Railsback SF: Agent-based simulation platforms: review and development recommendations. Simulation. 2006, 82: 609-23. 10.1177/0037549706073695.CrossRef
46.
go back to reference Diller AZ: An introduction to formal methods. . 1994, Chichester: John Wiley & Sons Ltd Diller AZ: An introduction to formal methods. . 1994, Chichester: John Wiley & Sons Ltd
47.
go back to reference Saltelli A, Cha K, Scott M, (Eds.): Sensitivity analysis Wiley series in probability and statistics. 2000, New York: John Wiley and Sons Saltelli A, Cha K, Scott M, (Eds.): Sensitivity analysis Wiley series in probability and statistics. 2000, New York: John Wiley and Sons
48.
go back to reference Klevmarken NA: Statistical inference in micro simulation models: Incorporating external information. Department of Economics Working Paper. 1998, Sweden: Uppsala University Klevmarken NA: Statistical inference in micro simulation models: Incorporating external information. Department of Economics Working Paper. 1998, Sweden: Uppsala University
49.
go back to reference Cronin KA, Legler JM, Etzioni RD: Assessing uncertainty in microsimulation modelling with application to cancer screening interventions. Stat Med. 1998, 17: 2509-23. 10.1002/(SICI)1097-0258(19981115)17:21<2509::AID-SIM949>3.0.CO;2-V.CrossRefPubMed Cronin KA, Legler JM, Etzioni RD: Assessing uncertainty in microsimulation modelling with application to cancer screening interventions. Stat Med. 1998, 17: 2509-23. 10.1002/(SICI)1097-0258(19981115)17:21<2509::AID-SIM949>3.0.CO;2-V.CrossRefPubMed
50.
go back to reference Campolongo F, Kleijnen J, Andres T: Screening methods. Sensitivity Analysis. Edited by: Saltelli A, Chan K, and Scott EM. 2000, New York: John Wiley and Sons Publishers, 65-80. Campolongo F, Kleijnen J, Andres T: Screening methods. Sensitivity Analysis. Edited by: Saltelli A, Chan K, and Scott EM. 2000, New York: John Wiley and Sons Publishers, 65-80.
51.
go back to reference Morris MD: Factorial sampling plans for preliminary computational experiments. Technometrics. 1991, 33: 161-174. 10.2307/1269043.CrossRef Morris MD: Factorial sampling plans for preliminary computational experiments. Technometrics. 1991, 33: 161-174. 10.2307/1269043.CrossRef
52.
go back to reference Cooke RM, Van Noordwejk JM: Generalized graphical methods for uncertainty and sensitivity analysis. Bashkiv Ecological Journal. 2000, 1: 54-57. Cooke RM, Van Noordwejk JM: Generalized graphical methods for uncertainty and sensitivity analysis. Bashkiv Ecological Journal. 2000, 1: 54-57.
53.
go back to reference Bojke L, Claxton K, Sculpher M, Palmer S: Characterizing structural uncertainty in decision analytic models: A review and application of methods. Value Health. 2009, 12: 739-49. 10.1111/j.1524-4733.2008.00502.x.CrossRefPubMed Bojke L, Claxton K, Sculpher M, Palmer S: Characterizing structural uncertainty in decision analytic models: A review and application of methods. Value Health. 2009, 12: 739-49. 10.1111/j.1524-4733.2008.00502.x.CrossRefPubMed
54.
go back to reference Mount Hood 4 Modeling Group: Computer modeling of diabetes and its complications: A report on the Fourth Mount Hood Challenge Meeting. Diabetes Care. 2007, 30: 1638-46. 10.2337/dc07-9919.CrossRef Mount Hood 4 Modeling Group: Computer modeling of diabetes and its complications: A report on the Fourth Mount Hood Challenge Meeting. Diabetes Care. 2007, 30: 1638-46. 10.2337/dc07-9919.CrossRef
55.
go back to reference Gerds TA, Cai T, Schumacher M: The performance of risk prediction models. Biom J. 2008, 50: 457-79. 10.1002/bimj.200810443.CrossRefPubMed Gerds TA, Cai T, Schumacher M: The performance of risk prediction models. Biom J. 2008, 50: 457-79. 10.1002/bimj.200810443.CrossRefPubMed
56.
go back to reference Schumacher M, Holländer N, Sauerbrei W: Resampling and cross-validation techniques: a tool to reduce bias caused by model building?. Stat Med. 1997, 16: 2813-27. 10.1002/(SICI)1097-0258(19971230)16:24<2813::AID-SIM701>3.0.CO;2-Z.CrossRefPubMed Schumacher M, Holländer N, Sauerbrei W: Resampling and cross-validation techniques: a tool to reduce bias caused by model building?. Stat Med. 1997, 16: 2813-27. 10.1002/(SICI)1097-0258(19971230)16:24<2813::AID-SIM701>3.0.CO;2-Z.CrossRefPubMed
Metadata
Title
Validation of population-based disease simulation models: a review of concepts and methods
Authors
Jacek A Kopec
Philippe Finès
Douglas G Manuel
David L Buckeridge
William M Flanagan
Jillian Oderkirk
Michal Abrahamowicz
Samuel Harper
Behnam Sharif
Anya Okhmatovskaia
Eric C Sayre
M Mushfiqur Rahman
Michael C Wolfson
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2010
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-10-710

Other articles of this Issue 1/2010

BMC Public Health 1/2010 Go to the issue